NP30925 Psychiatry and Neurology Medicines

Complete

Buyers

Value

£41,686,538

Classifications

  • Pharmaceutical products

Tags

  • tender

Submission Deadline

3 months ago

Published

4 months ago

Description

Supply of psychiatry and neurology medicines to NHS Scotland.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

Appt. of a Contract Manufacturing Organisation for Production of DST-F to GMP Standards

A Contract Manufacturing Organisation (CMO) certified to EU Good Manufacturing Practice (GMP) standards is required to work in partnership with the Authority to achieve UK Marketing Authorisation (MA) and, thereafter, undertake the scaled up production of the DST-F reagent, a diagnostic skin test to Detect Infected among Vaccinated Animals (DIVA). This will involve the technical transfer of the research grade fusion protein-based reagent from the current ISO-accredited provider.

Katy Reed

Katy Reed

Published 3 days ago
Open

NHS National Generic Pharmaceuticals - Wave 15c

NHS National Framework for Generic Pharmaceuticals - Wave 15c Offer reference number: CM/PHG/23/5699 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/23/5699/01 Oral (plus non-parenteral) products CESW/LSNE/NWLN 01/06/2026 to 31/05/2027 (12 months) CM/PHG/23/5699/02 Hospital only products DLS: 01/06/2026 to 31/05/2028 (24 months) DNE: 01/06/2026 to 31/05/2028 (24 months) CM/PHG/23/5699/03 Hospital only (housekeeping) products DLN/DNW 01/06/2026 to 31/01/2027 (8 months) DCE/DSW 01/06/2026 to 30/09/2027 (16 months)

Katy Reed

Katy Reed

Published 4 days ago
Open

NHS National Generic Pharmaceuticals - Wave 15c

NHS National Framework for Generic Pharmaceuticals - Wave 15c Offer reference number: CM/PHG/23/5699 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/23/5699/01 Oral (plus non-parenteral) products CESW/LSNE/NWLN 01/06/2026 to 31/05/2027 (12 months) CM/PHG/23/5699/02 Hospital only products DLS: 01/06/2026 to 31/05/2028 (24 months) DNE: 01/06/2026 to 31/05/2028 (24 months) CM/PHG/23/5699/03 Hospital only (housekeeping) products DLN/DNW 01/06/2026 to 31/01/2027 (8 months) DCE/DSW 01/06/2026 to 30/09/2027 (16 months)

Katy Reed

Katy Reed

Published 1 week ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Body governed by public law

[email protected]

+44 1312756000

Timeline complete